Last reviewed · How we verify
NCT04324762: DRAUP
Implementation of Ultrasound Guided Central Venous Catheter Confirmation Protocol
trial testing targetted implementation strategies in Behavior in 120 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 9 December 2019 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- targetted implementation strategies
Conditions studied
- Behavior — all drugs for Behavior →
- Process, Acceptance — all drugs for Process, Acceptance →
- Inertia of Accommodation — all drugs for Inertia of Accommodation →
Sponsor
Washington University School of Medicine
Who can join
18 and older, any sex, with Behavior or Process, Acceptance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The bedside use of ultrasound after central venous catheter (CVCs) insertion has lagged behind other applications in medicine, thus presenting an opportunity for innovative, evidence-based research that will influence clinician behavior. This research focuses on bedside ultrasound applications as an example, to evaluate clinical practice change. Chest radiographs are associated with delays in initiating time-critical interventions and present an unexamined opportunity for improving patient care by evaluating the use of ultrasound in lieu of chest radiographs after CVC insertion. Strategic interventions for implementation are needed to hasten the adoption of this clinical innovation (ultrasound guided CVC confirmation protocol) allowing them to de-implement chest xrays when no longer indicated.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Protocol for DRAUP: a deimplementation programme to decrease routine chest radiographs after central venous catheter insertion.
Ablordeppey EA, Powell B, McKay V, Keating S, et al · · 2021 · cited 1× · PMID 34663588 · DOI 10.1136/bmjoq-2020-001222 -
Study Protocol for Draup: De-implementation Ofroutine Chest Radiographs After Adoption of Ultrasound Guided Insertion and Confirmation of Central Venous Catheter Protocol, A Hybrid Implementation/effectiveness Study
Ablordeppey EA, Powell BJ, McKay VR, Keating SM, et al · · 2020 · DOI 10.21203/rs.3.rs-37859/v1
Verify or expand the search:
- PubMed search for NCT04324762
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Behavior
Currently open trials in the same condition.
- NCT07373626 — Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic · recruiting
- NCT06908447 — Cold Water and Decision-Making · NA · recruiting
- NCT07133529 — Decision-making and Food Intake · NA · recruiting
- NCT06862193 — Effectiveness of Digital Intervention (HM4MH-app) on Perinatal Psychological Wellbeing · NA · recruiting
- NCT06593613 — Pilot Trial of the RUBI Program for Autistic Adults · NA · recruiting
Other Washington University School of Medicine trials
Trials by the same sponsor.
- NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
- NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
- NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
- NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
- NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04324762 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
- Last refreshed: 4 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04324762.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing